Skip to main content
European Commission logo
IP Helpdesk
  • News article
  • 27 January 2025
  • European Innovation Council and SMEs Executive Agency
  • 1 min read

Singapore: Health Sciences Authority issues alert on adulterated and counterfeit health products

On 23 December 2024, the Health Sciences Authority (HSA) issued an alert to members of the public not to purchase or consume two products. The HSA’s analysis of the products revealed that one product contained potent medicinal ingredients, and the other was a counterfeit product. Both products have caused adverse effect in consumers, with one consumer even requiring hospitalization.

Sources

Details

Publication date
27 January 2025
Author
European Innovation Council and SMEs Executive Agency